Free Trial

Reckitt Benckiser Group (LON:RKT) Shares Up 2.2% - What's Next?

Reckitt Benckiser Group logo with Consumer Defensive background

Reckitt Benckiser Group plc (LON:RKT - Get Free Report) shares traded up 2.2% on Friday . The company traded as high as GBX 4,868 ($61.03) and last traded at GBX 4,847 ($60.76). 1,886,302 shares changed hands during trading, a decline of 41% from the average session volume of 3,203,260 shares. The stock had previously closed at GBX 4,741 ($59.43).

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Berenberg Bank reduced their price objective on shares of Reckitt Benckiser Group from GBX 5,200 ($65.19) to GBX 5,177 ($64.90) and set a "hold" rating for the company in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. lowered Reckitt Benckiser Group to a "neutral" rating in a report on Friday, August 30th. Finally, Jefferies Financial Group reissued a "hold" rating and issued a GBX 4,400 ($55.16) price objective on shares of Reckitt Benckiser Group in a research report on Monday, July 29th.

Get Our Latest Report on RKT

Reckitt Benckiser Group Stock Up 2.2 %

The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 112.52. The stock has a market capitalization of £33.50 billion, a P/E ratio of 2,233.64, a P/E/G ratio of 1.10 and a beta of 0.09. The stock's 50-day moving average price is GBX 4,714.96 and its two-hundred day moving average price is GBX 4,495.23.

Insiders Place Their Bets

In other Reckitt Benckiser Group news, insider Fiona Dawson acquired 25 shares of Reckitt Benckiser Group stock in a transaction that occurred on Wednesday, October 23rd. The stock was acquired at an average cost of GBX 4,923 ($61.71) per share, for a total transaction of £1,230.75 ($1,542.87). Company insiders own 0.05% of the company's stock.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

See Also

Should you invest $1,000 in Reckitt Benckiser Group right now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

SoundHound Stock Explodes Again – Is a Major Breakout Coming?

SoundHound Stock Explodes Again – Is a Major Breakout Coming?

With 25% short interest, profit-taking risks, and a hyper-growth phase, this stock is at a critical turning point. Will it soar or stumble?

Related Videos

3 High Short Interest Stocks You Need to Watch
SoundHound: The AI Stock That’s Up 100% – Could It Double Again Soon?
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines